April 17th 2024
Harnessing these tools for successful integration and streamlining of processes.
The Role of Human Oversight With Artificial Intelligence in Clinical Research
April 12th 2024In the fifth and final part of this video interview with ACT editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, Parexel, highlights the importance of human oversight when using artificial intelligence to aid in decision making.
Benefits Patients Will See With the Integration of AI Into Clinical Research
April 11th 2024In part 4 of this video interview with ACT editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, Parexel, spotlights the importance of considering the experience of patients when integrating artificial intelligence as well as some of the benefits they will see from it.
The State of AI in Clinical Development
April 8th 2024In part 1 of this video interview with ACT editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, Parexel, gives a broad overview of the use of artificial intelligence in clinical development and how regulatory bodies are viewing it.
Phase III Trial to Evaluate Novel KRAS G12C Covalent Inhibitor Plus Keytruda for NSCLC
Trial to analyze novel therapy MK-1084 plus Keytruda (pembrolizumab) in certain patients with metastatic non-small cell lung cancer whose tumors harbor KRAS G12C mutations and express PD-L1.